FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004355336> ?p ?o ?g. }

• W2004355336 endingPage "2210" @default.
• W2004355336 startingPage "2205" @default.
• W2004355336 abstract "Tetrandrine (TET), a bisbenzylisoquinoline alkaloid isolated from the root of Hang-Fang-Chi (Stephania tetrandra S. Moore), exhibits broad pharmacological effects, including antitumor activity in various malignant neoplasms. Recently, the beneficial effects of TET on cytotoxicity towards tumor cells, radiosensitization, circumventing multidrug resistance, normal tissue radioprotection, and antiangiogenesis have been examined extensively. However, the potential molecular mechanisms of the effect on glioma of TET are yet unknown. This study is explored to evaluate whether TET can inhibit cell proliferation, invasion, and the possible underlying mechanisms in glioma U87 cell. In the present study, cell proliferation was determined by using the Cell Counting Kit-8 (CCK-8) viability assay. The invasion and migration were evaluated by means of wound-scratch assay and Matrigel-Transwell methods. The mRNA expression and protein expression of ADAM metallopeptidase domain 17 (ADAM17) in glioma cell lines and glioma samples were determined by reverse transcription–polymerase chain reaction (RT-PCR) and Western blotting, respectively. Moreover, the expression of epidermal growth factor receptor (EGFR)/p-EGFR and AKT/p-AKT was studied to clarify the molecular mechanism. Our results suggested that TET inhibited cell proliferation in a dose- and time-dependent manner, and cell migration and invasion in vitro. In addition, our results indicated that ADAM17 expression significantly increased in glioma compared to nontumored human brain tissue and according to the histopathological grade of glioma. Western blot analysis showed that protein expressions of ADAM17, p-EGFR, and p-AKT were inhibited by TET in U87 cells. These data also suggest that suppression of ADAM17 and downregulation of EGFR–phosphoinositide-3-kinase (PI3K)–AKT signaling pathways may contribute to TET-induced decrease of proliferation, migration, and invasiveness." @default.
• W2004355336 created "2016-06-24" @default.
• W2004355336 creator A5002621017 @default.
• W2004355336 creator A5002929656 @default.
• W2004355336 creator A5004206316 @default.
• W2004355336 creator A5026780889 @default.
• W2004355336 creator A5026874793 @default.
• W2004355336 creator A5028330071 @default.
• W2004355336 creator A5039180109 @default.
• W2004355336 creator A5066629372 @default.
• W2004355336 creator A5070999062 @default.
• W2004355336 creator A5079874882 @default.
• W2004355336 creator A5083494970 @default.
• W2004355336 creator A5084454442 @default.
• W2004355336 date "2013-11-03" @default.
• W2004355336 modified "2023-10-15" @default.
• W2004355336 title "Effects of tetrandrine on glioma cell malignant phenotype via inhibition of ADAM17" @default.
• W2004355336 cites W1975078638 @default.
• W2004355336 cites W1975424430 @default.
• W2004355336 cites W1982692351 @default.
• W2004355336 cites W1995337883 @default.
• W2004355336 cites W1998646933 @default.
• W2004355336 cites W2002465136 @default.
• W2004355336 cites W2014886449 @default.
• W2004355336 cites W2023504792 @default.
• W2004355336 cites W2035228001 @default.
• W2004355336 cites W2047287811 @default.
• W2004355336 cites W2057458801 @default.
• W2004355336 cites W2072219853 @default.
• W2004355336 cites W2085370249 @default.
• W2004355336 cites W2123155385 @default.
• W2004355336 cites W2140561713 @default.
• W2004355336 cites W2152146255 @default.
• W2004355336 cites W2158681922 @default.
• W2004355336 cites W2163859522 @default.
• W2004355336 cites W4242403727 @default.
• W2004355336 doi "https://doi.org/10.1007/s13277-013-1293-y" @default.
• W2004355336 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24185966" @default.
• W2004355336 hasPublicationYear "2013" @default.
• W2004355336 type Work @default.
• W2004355336 sameAs 2004355336 @default.
• W2004355336 citedByCount "25" @default.
• W2004355336 countsByYear W20043553362014 @default.
• W2004355336 countsByYear W20043553362015 @default.
• W2004355336 countsByYear W20043553362016 @default.
• W2004355336 countsByYear W20043553362017 @default.
• W2004355336 countsByYear W20043553362018 @default.
• W2004355336 countsByYear W20043553362019 @default.
• W2004355336 countsByYear W20043553362020 @default.
• W2004355336 countsByYear W20043553362022 @default.
• W2004355336 countsByYear W20043553362023 @default.
• W2004355336 crossrefType "journal-article" @default.
• W2004355336 hasAuthorship W2004355336A5002621017 @default.
• W2004355336 hasAuthorship W2004355336A5002929656 @default.
• W2004355336 hasAuthorship W2004355336A5004206316 @default.
• W2004355336 hasAuthorship W2004355336A5026780889 @default.
• W2004355336 hasAuthorship W2004355336A5026874793 @default.
• W2004355336 hasAuthorship W2004355336A5028330071 @default.
• W2004355336 hasAuthorship W2004355336A5039180109 @default.
• W2004355336 hasAuthorship W2004355336A5066629372 @default.
• W2004355336 hasAuthorship W2004355336A5070999062 @default.
• W2004355336 hasAuthorship W2004355336A5079874882 @default.
• W2004355336 hasAuthorship W2004355336A5083494970 @default.
• W2004355336 hasAuthorship W2004355336A5084454442 @default.
• W2004355336 hasConcept C104317684 @default.
• W2004355336 hasConcept C128473837 @default.
• W2004355336 hasConcept C1491633281 @default.
• W2004355336 hasConcept C153911025 @default.
• W2004355336 hasConcept C170493617 @default.
• W2004355336 hasConcept C185592680 @default.
• W2004355336 hasConcept C2776415932 @default.
• W2004355336 hasConcept C2778227246 @default.
• W2004355336 hasConcept C2778608917 @default.
• W2004355336 hasConcept C2779438470 @default.
• W2004355336 hasConcept C2779934757 @default.
• W2004355336 hasConcept C2780394083 @default.
• W2004355336 hasConcept C2780783641 @default.
• W2004355336 hasConcept C502942594 @default.
• W2004355336 hasConcept C53227056 @default.
• W2004355336 hasConcept C54355233 @default.
• W2004355336 hasConcept C55493867 @default.
• W2004355336 hasConcept C62112901 @default.
• W2004355336 hasConcept C62478195 @default.
• W2004355336 hasConcept C75217442 @default.
• W2004355336 hasConcept C81885089 @default.
• W2004355336 hasConcept C85265743 @default.
• W2004355336 hasConcept C86554907 @default.
• W2004355336 hasConcept C86803240 @default.
• W2004355336 hasConcept C95444343 @default.
• W2004355336 hasConcept C98274493 @default.
• W2004355336 hasConceptScore W2004355336C104317684 @default.
• W2004355336 hasConceptScore W2004355336C128473837 @default.
• W2004355336 hasConceptScore W2004355336C1491633281 @default.
• W2004355336 hasConceptScore W2004355336C153911025 @default.
• W2004355336 hasConceptScore W2004355336C170493617 @default.
• W2004355336 hasConceptScore W2004355336C185592680 @default.
• W2004355336 hasConceptScore W2004355336C2776415932 @default.
• W2004355336 hasConceptScore W2004355336C2778227246 @default.

• next